Andre Branch
Known title: DirectorCIK: 0001845034
Associated companies
Transaction History
| SIG | ▲ Buy | Grant | 2,018 | $0 | 6/26/2026 | View on chart |
| SIG | ▲ Buy | Grant | 9 | $0 | 5/22/2026 | View on chart |
| SIG | ▲ Buy | Grant | 7 | $0 | 2/20/2026 | View on chart |
| SIG | ▲ Buy | Grant | 7 | $0 | 11/21/2025 | View on chart |
| SIG | ▲ Buy | Grant | 8 | $0 | 8/22/2025 | View on chart |
| SIG | ▲ Buy | Grant | 2,014 | $0 | 7/1/2025 | View on chart |
| SIG | ▼ Sell | Open Market | 5,679 | $369K | 5/8/2025 | View on chart |
| SIG | ▲ Buy | Grant | 1,641 | $0 | 6/28/2024 | View on chart |
| SIG | ▲ Buy | Grant | 2,467 | $0 | 6/16/2023 | View on chart |
| SIG | ▲ Buy | Grant | 2,667 | $0 | 6/17/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
Signet Shares Rise 8.4% Post-Earnings; Blue Nile Partners with Royal Asscher
Signet shares have climbed 8.4% since the last earnings report, moving against a broader market dip. The company also announced that its Blue Nile brand is partnering with Royal Asscher, a move that may strengthen its product lineup. With an average analyst target of $125.90, the stock remains well below that level, sitting near its 52-week high of $110.20.
Signet Shares Rise 8.4% Post-Earnings; Blue Nile Partners with Royal Asscher. Signet shares have climbed 8.4% since the last earnings report, moving against a broader market dip. The company also announced that its Blue Nile brand is partnering with Royal Asscher, a move that may strengthen its product lineup. With an average analyst target of $125.90, the stock remains well below that level, sitting near its 52-week high of $110.20.